The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AERIE PHARMACEUTICALS INC | NOTE 1.500%10/0 | 00771VAB4 | 2,931 | 3,675,000 | SH | SOLE | 3,675,000 | 0 | 0 | ||
AKAMAI TECHNOLOGIES INC | NOTE 0.375% 9/0 | 00971TAL5 | 20,246 | 17,500,000 | SH | SOLE | 17,500,000 | 0 | 0 | ||
BENTLEY SYS INC | COM CL B | 08265T208 | 785 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
HUMANIGEN INC | COM NEW | 444863203 | 8,778 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
IAC INTERACTIVECORP NEW | COM | 44891N109 | 21,407 | 178,722 | SH | SOLE | 178,722 | 0 | 0 | ||
MATCH GROUP INC NEW | COM | 57667L107 | 86,821 | 784,643 | SH | SOLE | 784,643 | 0 | 0 | ||
PINDUODUO INC | NOTE 10/0 | 722304AB8 | 456 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
RENALYTIX AI PLC | ADS | 75973T101 | 1,219 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SNAP INC | NOTE 0.750% 8/0 | 83304AAB2 | 16,613 | 12,000,000 | SH | SOLE | 12,000,000 | 0 | 0 | ||
SUMMIT THERAPEUTICS INC | COM | 86627T108 | 17,200 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
VERTEX INC | CL A | 92538J106 | 2,783 | 121,000 | SH | SOLE | 121,000 | 0 | 0 |